Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 2 (2005), Issue 10 (October)

1. Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease.
   Curr Med Res Opin, 21(9): 1423-9. [Abstract] [Full-text]
2. History of genetic disease: the molecular genetics of Huntington disease - a history.
   Nat Rev Genet, 6(10): 766-73. [Abstract] [Full-text]
3. Brief report: errorless versus errorful learning as a memory rehabilitation approach in Alzheimer's Disease.
   J Clin Exp Neuropsychol, 27(8): 1070-9. [Abstract] [Full-text]
4. Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection.
   Life Sci, 77(24): 3092-104. [Abstract] [Full-text]
5. Mortality is associated with apolipoprotein E epsilon4 in nondemented adults with Down syndrome.
   Neurosci Lett, 390(2): 93-7. [Abstract] [Full-text]
6. Presenilin 1 Glu318Gly polymorphism: interpret with caution.
   Arch Neurol, 62(10): 1624-7. [Abstract] [Full-text]
7. Delusions and hallucinations are associated with worse outcome in Alzheimer disease.
   Arch Neurol, 62(10): 1601-8. [Abstract] [Full-text]
8. Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
   Arch Neurol, 62(10): 1591-4. [Abstract] [Full-text]
9. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.
   Arch Neurol, 62(10): 1556-60. [Abstract] [Full-text]
10. Risk factors associated with beta-amyloid(1-42) immunotherapy in preimmunization gene expression patterns of blood cells.
    Arch Neurol, 62(10): 1531-6. [Abstract] [Full-text]
11. Housing and dementia care - a scoping review of the literature.
    Health Soc Care Community, 13(6): 570-7. [Abstract] [Full-text]
12. Age at onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD).
    BMC Med Genet, 6: 35. [Abstract] [Full-text]
13. Creutzfeldt-Jakob disease in the obstetric patient.
    J Obstet Gynecol Neonatal Nurs, 34(5): 546-50. [Abstract] [Full-text]
14. Homocysteine and methylmalonic acid concentrations in cerebrospinal fluid: relation with age and Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 76(11): 1585-7. [Abstract] [Full-text]
15. Saccade impairments in patients with fronto-temporal dementia.
    J Neurol Neurosurg Psychiatry, 76(11): 1581-4. [Abstract] [Full-text]
16. Differential impairment of spatial location memory in Huntington's disease.
    J Neurol Neurosurg Psychiatry, 76(11): 1516-9. [Abstract] [Full-text]
17. Phenotypic variability in familial prion diseases due to the D178N mutation.
    J Neurol Neurosurg Psychiatry, 76(11): 1491-6. [Abstract] [Full-text]
18. Mild cognitive impairment in different functional domains and incident Alzheimer's disease.
    J Neurol Neurosurg Psychiatry, 76(11): 1479-84. [Abstract] [Full-text]
19. Transgenic mice expressing mutant (N279K) human tau show mutation dependent cognitive deficits without neurofibrillary tangle formation.
    FEBS Lett, 579(25): 5704-12. [Abstract] [Full-text]
20. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
    Neurochem Int, 47(8): 589-96. [Abstract] [Full-text]
21. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials.
    JAMA, 294(15): 1934-43. [Abstract] [Full-text]
22. Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease.
    J Biosci Bioeng, 99(5): 437-47. [Abstract] [Full-text]
23. Frontotemporal dementia.
    Lancet Neurol, 4(11): 771-80. [Abstract] [Full-text]
24. Poststroke dementia.
    Lancet Neurol, 4(11): 752-9. [Abstract] [Full-text]
25. Behavioural changes and psychological symptoms in dementia disorders.
    Lancet Neurol, 4(11): 735-42. [Abstract] [Full-text]
26. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease.
    Lancet Neurol, 4(11): 705-11. [Abstract] [Full-text]
27. Reciprocal interference between specific CJD and scrapie agents in neural cell cultures.
    Science, 310(5747): 493-6. [Abstract] [Full-text]
28. Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis.
    Glia, 52(4): 344-53. [Abstract] [Full-text]
29. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Mol Psychiatry, 10(11): 1026-36. [Abstract] [Full-text]
30. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.
    J Cereb Blood Flow Metab, 25(11): 1528-47. [Abstract] [Full-text]
31. Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.
    J Neurochem, 95(3): 834-47. [Abstract] [Full-text]
32. Neuroanatomical correlates of behavioural disorders in dementia.
    Brain, 128: 2612-25. [Abstract] [Full-text]
33. Measurement of basal forebrain atrophy in Alzheimer's disease using MRI.
    Brain, 128: 2626-44. [Abstract] [Full-text]
34. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology.
    Brain, 128: 2645-53. [Abstract] [Full-text]

© 2004-2012 Dementia Research Today. All Rights Reserved.